Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas

Genes and Cancer

Volumn 2, Issue 8, 2011, Pages 829-840

  Graham, Lloyd D ^a   Pedersen, Susanne K ^b   Brown, Glenn S ^a   Ho, Thu ^a   Kassir, Zena ^a,c   Moynihan, Audrey T ^a   Vizgoft, Emma K ^b   Dunne, Robert ^a   Pimlott, Letitia ^d   Young, Graeme P ^d   LaPointe, Lawrence C ^b   Molloy, Peter L ^a  

^a CSIRO   (Australia)

^b Clinical Genomics Pty Ltd   (Australia)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d FLINDERS UNIVERSITY   (Australia)

Author keywords

colorectal adenoma; colorectal cancer; colorectal neoplasia; CRNDE; RNA biomarker

Indexed keywords

RNA; TUMOR MARKER;

5' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COLORECTAL NEOPLASIA DIFFERENTIALLY EXPRESSED GENE; CONTROLLED STUDY; EXON; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; UPREGULATION;

EID: 84859152071     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911431081     Document Type: Article

References (36)

1. Stein U,Schlag PM.Clinical, biological, and molecular aspects of metastasis in colorectal cancer.Recent Results Cancer Res. 2007;176:61-80.
2. Hewitson P,Glasziou PP,Irwig L,Towler B,Watson E.Screening for colorectal cancer using the faecal occult blood test, Hemoccult.Cochrane Database Syst Rev. 2007; (1): CD001216.
3. Cunningham D,Atkin W,Lenz H-J, et al.Colorectal cancer.Lancet. 2010;375:1030-47.
4. Atkin WS,Edwards R,Kralj-Hans I, et al.UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.Lancet. 2010;375:1624-33.
5. Young GP.Population-based screening for colorectal cancer: Australian research and implementation.J Gastroenterol Hepatol. 2009;24:S33-42.
6. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2: Cancer incidence and mortality worldwide. IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Cited 29 Sep 2011. Available from: http://globocan.iarc.fr.
7. Ransohoff DF.Rules of evidence for cancer molecular-marker discovery and validation.Nat Rev Cancer. 2004;4:309-12.
8. Hundt S,Haug U,Brenner H.Blood markers for early detection of colorectal cancer: a systematic review.Cancer Epidemiol Biomarkers Prev. 2007;16:1935-53.
9. Chan SK,Griffith OL,Tai IT,Jones SJM.Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers.Cancer Epidemiol Biomarkers Prev. 2008;17:543-52.
10. Nagaraj SH,Reverter A.A Boolean-based systems biology approach to predict novel genes associated with cancer: application to colorectal cancer.BMC Syst Biol. 2011;5:e35.
11. Srebrow A,Kornblihtt AR.The connection between splicing and cancer.J Cell Sci. 2006;119:2635-41.
12. Thorsen K,Sørensen KD,Brems-Eskildsen AS, et al.Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis.Mol Cell Proteomics. 2008;7:1214-24.
13. Venables JP,Klinck R,Koh C, et al.Cancer-associated regulation of alternative splicing.Nat Struct Mol Biol. 2009;16:670-6.
14. Ritchie W,Granjeaud S,Puthier D,Gautheret D.Entropy measures quantify global splicing disorders in cancer.PLoS Comput Biol. 2008;4:e1000011.
15. Wittig BM,Goebel R,Weg-Remers S, et al.Stage-specific alternative splicing of CD44 and alpha-6 beta-1 integrin in colorectal tumorigenesis.Exp Mol Pathol. 2001;70:96-102.
16. Li HR,Wang-Rodriguez J,Nair TM, et al.Two-dimensional transcriptome profiling: identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens.Cancer Res. 2006;66:4079-88.
17. André F,Michiels S,Dessen P, et al.Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis.Lancet Oncol. 2009;10:381-90.
18. Sabates-Bellver J,Van der Flier LG,de Palo M, et al.Transcriptome profile of human colorectal adenomas.Mol Cancer Res. 2007;5:1263-75.
19. Kaneda H,Arao T,Tanaka K, et al.FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth.Cancer Res. 2010;70:2053-63.
20. Hong Y,Ho KS,Eu KW,Cheah PY.A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis.Clin Cancer Res. 2007;13:1107-14.
21. Cabili MN,Trapnell C,Goff L, et al.Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses.Genes Dev. 2011;25:1915-27.
22. Kondo T,Plaza S,Zanet J, et al.Small peptides switch the transcriptional activity of Shavenbaby during Drosophila embryogenesis.Science. 2010;329:336-9.
23. Khalil AM,Guttman M,Huarte M, et al.Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression.Proc Natl Acad Sci U S A. 2009;106:11667-72.
24. LaPointe LC,Dunne R,Brown GS, et al.Map of differential transcript expression in the normal human large intestine.Physiol Genomics. 2008;33:50-64.
25. Guttman M,Donaghey J,Carey BW, et al.lincRNAs act in the circuitry controlling pluripotency and differentiation.Nature. 2011;477:295-300.
26. Lin M,Pedrosa E,Shah A, et al.RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders.PLoS One. 2011;6:e23356.
27. Chang Q,Chen J,Beezhold KJ,Castranova V,Shi X,Chen F.JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma.Mol Cancer. 2009;8:e64.
28. Levin B,Lieberman D,McFarland B, et al.Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.Gastroenterology. 2008;134:1570-95.
29. Hong BS,Cho JH,Kim H, et al.Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells.BMC Genomics. 2009;10:e556.
30. Rabinowits G,Gerçel-Taylor C,Day JM,Taylor DD,Kloecker GH.Exosomal microRNA: a diagnostic marker for lung cancer.Clin Lung Cancer. 2009;10:42-6.
31. Wittmann J,Jäck HM.Serum microRNAs as powerful cancer biomarkers.Biochim Biophys Acta. 2010;1806:200-7.
32. Nilsson J,Skog J,Nordstrand A, et al.Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer.Br J Cancer. 2009;100:1603-7.
33. Nissan A,Stojadinovic A,Mitrani-Rosenbaum S, et al.Colon cancer associated transcript-1 (CCAT1): a novel RNA expressed in malignant and pre-malignant human tissues. Int J Cancer.
34. Tsai MC,Spitale RC,Chang HY.Long intergenic noncoding RNAs: new links in cancer progression.Cancer Res. 2011;71:3-7.
35. Pradervand S,Paillusson A,Thomas J, et al.Affymetrix Whole-Transcript Human Gene 1.0 ST array is highly concordant with standard 3′ expression arrays.Biotechniques. 2008;44:759-62.
36. Hsu F,Kent WJ,Clawson H,Kuhn RM,Diekhans M,Haussler D.The UCSC known genes.Bioinformatics. 2006;22:1036-46.